RA
NSPR icon

Rosalind Advisors’s InspireMD NSPR Stock Holding History

Rosalind Advisors’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73M Hold
3,905,743
– – 1.02% 21
2026
Q1 		$6.37M Hold
3,905,743
– – 2.56% 15
2025
Q4 		$6.95M Hold
3,905,743
– – 2.44% 17
2025
Q3 		$9.41M Buy
3,905,743
+1,616,644
+71% +$3.92M 3.22% 13
2025
Q2 		$5.2M Buy
2,289,099
+14,109
+0.6% +$35.2K 2.46% 17
2025
Q1 		$6.12M Sell
2,274,990
-220,793
-9% -$625K 2.98% 15
2024
Q4 		$6.56M Sell
2,495,783
-18,263
-0.7% -$49.1K 3.36% 13
2024
Q3 		$6.74M Buy
2,514,046
+405
+0% +$1.1K 4.31% 11
2024
Q2 		$6.27M Buy
2,513,641
+1,827,579
+266% +$4.28M 4.83% 8
2024
Q1 		$1.63M Sell
686,062
-239,132
-26% -$645K 1.52% 21
2023
Q4 		$2.6M Buy
+925,194
New +$2.66M 2.14% 18

Other funds holding NSPR

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Rosalind Advisors's NSPR Position: Q2 2026 in Review

Rosalind Advisors held its InspireMD (NSPR) position steady in Q2 2026 at 3,905,743 shares worth $2.73M. The position accounts for 1.02% of the portfolio, ranked #21.

Rosalind Advisors first reported a position in NSPR in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.41M in Q3 2025. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Rosalind Advisors held 3,905,743 shares of InspireMD worth $2.73M as of Q2 2026.
  • Rosalind Advisors left its InspireMD share count unchanged in Q2 2026.
  • InspireMD made up 1.02% of Rosalind Advisors's portfolio in Q2 2026, its #21 holding.
  • Rosalind Advisors first reported a position in InspireMD in Q4 2023 and has held it in 11 quarters since.
  • Rosalind Advisors's InspireMD position peaked at $9.41M in Q3 2025.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Rosalind Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.